Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BNP Sunscreen Safety and Efficacy Study
NCT02668536Phase 1Completed
- Sponsor
- Yale University
- Start
- Jul 2017
- Primary completion
- Aug 2017
- Countries
- 1
01
Overview
Phase 1, randomised trial in melanoma (4 arms), sponsored by Yale University. Primary endpoints: Skin Reaction at 1 week and Sun Protection Factor at 1 week. Started Jul 2017; status: completed.
02
Conditions
melanoma
Beyond the preview
Go deeper on NCT02668536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02668536.